UK and Ireland medical cannabis access programmes and education slowly progress

medical cannabis access
© Tinnakorn Jorruang |

GreenLight Pharmaceuticals Ltd is advancing clinical research and education in UK and Ireland; Though government progress on access and prescribing recommendations lags behind much of Europe

GreenLight and Medical Cannabis

Established in 2014, GreenLight Pharmaceuticals Ltd is an Irish biopharmaceutical company focused on developing safe and effective plant-based medicines. GreenLight specialises in phytocannabinoid research and clinical development.

‘Medical cannabis’ (cannabis-based medical products (CBMP)) refers to a range of products that contain active compounds (primarily Δ9-tetrahydrocannabinol (THC) and cannabidiol (CBD)), either synthesized chemically, isolated from plant or raw plant preparations.

In the past decade Germany, Italy, France, Spain and Switzerland have implemented medical cannabis access programmes for particular indications (Figure 1). In 2018 Ireland and UK also permitted medical use, however, the

... read more at: https://www.openaccessgovernment.org/medical-cannabis-access/66811/

Leave a Reply